Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

From molecular regulation to tissue repair: hydrogels in the fight against intervertebral disc degeneration

Zhang J., Wang Z., Chen S., Li L., Zhang Y., Shang C.

Narrative Review on Back Pain, Disc Degeneration, published in Ann Med (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Ann Med (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41084298
PMCID
PMC12523452
DOI
10.1080/07853890.2025.2572310
Citations
5

Abstract (original English)

Background Intervertebral disc degeneration (IVDD) is a leading cause of low back pain and involves multiple pathological processes, including cell apoptosis, senescence, oxidative stress-inflammation imbalance, and extracellular matrix (ECM) metabolic disorders. Current treatments such as pharmacotherapy, physical therapy, and surgery primarily relieve symptoms but fail to reverse the degenerative process and often carry the risk of complications. Methods This review systematically summarizes recent advances in the functional design and therapeutic applications of hydrogels for IVDD, with a focus on delivery systems, microenvironment modulation, and stimulus-responsive mechanisms. In vivo studies and preliminary clinical findings are also reviewed. Results Hydrogels have emerged as a promising strategy for IVDD regenerative therapy due to their excellent biocompatibility, injectability, and dynamic responsiveness. Acting as multifunctional platforms, hydrogels can precisely deliver stem cells, exosomes, and nucleic acid drugs, regulate apoptotic pathways (e.g. Bax/Bcl-2, Caspase-3), suppress pro-inflammatory cytokines (e.g. TNF-α, IL-1β), and promote ECM synthesis (e.g. collagen II and proteoglycans). Additionally, the incorporation of antioxidant nanoparticles and stimuli-responsive systems allows for effective remodeling of the degenerative microenvironment and interruption

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Extracellular MatrixAnimalsHumansHydrogelsDrug Delivery SystemsOxidative StressIntervertebral Disc Degeneration

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research